Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,731 across all filing types
Latest filing 2026-05-16 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 55% confidence The provided text is a notice to stock exchanges scheduling and rescheduling a teleconference with investors/analysts to discuss quarterly/year-end financial performance. It does not include any financial results, Q&A transcript, actual report content, or data but is purely a regulatory announcement of a conference call. It therefore falls under the generic “Regulatory Filings” category (RNS).
2026-05-16 English
Analyst Call - rescheduled
Regulatory Filings Classification · 75% confidence The document contains letters to stock exchanges (BSE & NSE) announcing and rescheduling a quarterly financial results conference call with investors/analysts. It does not provide any actual financial data or the transcript itself, nor is it the publication of a quarterly report. Instead, it is a regulatory announcement of a teleconference schedule. There is no dedicated category for a call invitation, so it falls under the general regulatory announcements (RNS).
2026-05-16 English
Post Quarterly Financial Result Conference call with investors / analyst
Regulatory Filings Classification · 91% confidence The document is a stock exchange filing notifying investors/analysts of a scheduled teleconference to discuss quarterly and annual financial results. It does not contain any financial statements, earnings highlights, or actual data, nor is it the minutes or transcript of the call. It is an announcement-type regulatory filing. There is no specific category for a conference call invite, so under the fallback classification it should be Regulatory Filings (RNS).
2026-05-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a notice to stock exchanges announcing the scheduling of a post‐quarterly financial results teleconference with investors/analysts. It does not include any financial data itself, nor is it a transcript, presentation deck, earnings release, or report publication announcement. It is a general regulatory announcement, so it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-12 English
Post Quarterly Financial Result Conference call with investors / analyst
Regulatory Filings Classification · 85% confidence The document is a formal notice to stock exchanges under listing obligations announcing a scheduled post-quarterly financial results conference call with investors/analysts. It does not contain financial data or results, nor is it the transcript of the call. It is not an earnings release (no key financial highlights are provided) but rather a regulatory announcement. This fits the catch-all category for regulatory announcements that do not fit other specific types: Regulatory Filings (RNS).
2026-05-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 82% confidence The document is a formal notice to stock exchanges announcing the scheduling of a post-quarterly-results teleconference (earnings call) with investors/analysts. It contains no financial results, detailed presentation materials, nor a transcript, but simply provides dial-in details and timing. This does not qualify as an earnings release (ER) since no results are disclosed, nor as a call transcript (CT) because the call has not yet occurred. It is a general regulatory announcement, best classified under Regulatory Filings (RNS).
2026-05-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.